Insights On Enterprise Solutions
-
From The Floor At CPHI 2025: Takeaways Everyone Should Know
12/23/2025
Gain insights into evolving pharma priorities, from supply chain resilience to advanced manufacturing, and why flexibility, scalability, and technical expertise matter in a dynamic global market.
-
CDMO Capabilities Overview
12/23/2025
Explore global CDMO capabilities that streamline drug development and manufacturing, leveraging advanced infrastructure and regulatory expertise from early formulation through commercial production.
-
Zhunan Facility Site VR Tour
12/23/2025
Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.
-
Corporate Overview 2025: Business Strategy & Outlook
12/23/2025
Explore how a growing pharma organization uses innovation, regulatory expertise, and strategic partnerships to deliver targeted therapies and drive impact across the evolving healthcare landscape.
-
State-Of-The-Art CDMO Facility - Maple Grove
12/22/2025
Discover how a U.S.-based CDMO combines advanced infrastructure, quality-driven processes, and flexible manufacturing to support pharmaceutical development and commercial supply.
-
The Impact Of PEGs In The Small Molecule API Market
12/22/2025
Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.
-
Periodic Counter Current Chromatography: A Step Toward Continuous DSP
12/19/2025
PCC boosts Protein A capture efficiency, cuts resin costs, increases productivity, and enables continuous downstream processing without sacrificing quality or compliance.
-
Agile Adaptation In mRNA-LNP Manufacturing: A CDMO's Response
12/17/2025
Find flexible scale-up from lab through commercial manufacturing, leveraging expertise. Gain technical insights for scalable, efficient development for advancing mRNA, saRNA, or circular RNA programs.
-
Combining AI With Operations Research To Advance Biomanufacturing With Tinglong Dai, Ph.D., and Tugce Martagan, Ph.D.
12/16/2025
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Tinglong Dai, Ph.D., Bernard T. Ferrari Professor of Business at Johns Hopkins University, and Tugce Martagan, Ph.D., associate professor at Northeastern University, to talk about the potential advancements that can be made in biomanufacturing by combining AI with operations research (OR).
-
Tech Transfer Answers: How To Successfully Onshore A Mid-Phase Project
12/16/2025
Onshoring biomanufacturing operations is an increasingly common decision. While a mid-phase tech transfer from international to domestic CDMO can be complex, the right partner can ensure success.